Sunshine Biopharma Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Sunshine Biopharma Inc. (SBFM) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $5.56 thousand as of 2019-03-31, per its 10-Q filed 2019-05-20.
Discontinued › Notes
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2019-05-20
- 2019-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.56K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2019-03-31 | $5.56K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |